FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199164501> ?p ?o ?g. }

• W3199164501 abstract "Background. Direct-acting antiviral (DAA) drugs have been effective in the treatment of chronic hepatitis C virus (HCV) infection. Limited data are available on safety, tolerability, and efficacy in American Indian or Alaska Native people. We aim to evaluate the treatment outcomes of sofosbuvir-based regimens for treatment of HCV in a real life setting in Alaska Native/American Indian (AN/AI) people. Methods. AN/AI patients within the Alaska Tribal Health System with confirmed positive anti-HCV and HCV RNA, who were 18 years of age and older were included in the study. Pretreatment baseline patient characteristics, treatment efficacy based on sustained virologic response (SVR) 12 weeks after treatment completion, and adverse effects were assessed. The following treatments were given according to the American Association for the Study of Liver Diseases/Infectious Disease Society of America (AASLD/IDSA) HCV Guidance: ledipasvir/sofosbuvir, sofosbuvir plus weight-based ribavirin, and sofosbuvir/velpatasvir. Results. We included 501 patients with a mean age of 54.3 (range 21.3 -78.3) in the study. Overall SVR was achieved in 95.2% of patients who received one of the three DAA regimens. For those with cirrhosis, overall SVR was 92.8% and for those with genotype 3 91.1% achieved SVR. The most common symptom experienced during treatment was headache. Joint pain was found to decrease during treatment. One person discontinued sofosbuvir plus ribavirin due to myocardial infarction and one discontinued sofosbuvir/velpatasvir due to urticaria. Conclusions. In the real-world setting, sofosbuvir-based treatment is safe, effective, and well tolerated in AN/AI patients. Sustained virologic response was high regardless of HCV genotype or cirrhosis status." @default.
• W3199164501 created "2021-09-27" @default.
• W3199164501 creator A5000280092 @default.
• W3199164501 creator A5012480603 @default.
• W3199164501 creator A5014466276 @default.
• W3199164501 creator A5019579007 @default.
• W3199164501 creator A5023494741 @default.
• W3199164501 creator A5026246111 @default.
• W3199164501 creator A5049397082 @default.
• W3199164501 creator A5051260628 @default.
• W3199164501 creator A5057099256 @default.
• W3199164501 creator A5065120166 @default.
• W3199164501 creator A5081891723 @default.
• W3199164501 creator A5083663416 @default.
• W3199164501 creator A5086050635 @default.
• W3199164501 creator A5087874003 @default.
• W3199164501 creator A5091766125 @default.
• W3199164501 date "2021-09-10" @default.
• W3199164501 modified "2023-10-15" @default.
• W3199164501 title "The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals" @default.
• W3199164501 cites W1479990585 @default.
• W3199164501 cites W1881009043 @default.
• W3199164501 cites W1973675889 @default.
• W3199164501 cites W2000307707 @default.
• W3199164501 cites W2035804055 @default.
• W3199164501 cites W2036913245 @default.
• W3199164501 cites W2094269287 @default.
• W3199164501 cites W2095892942 @default.
• W3199164501 cites W2101598010 @default.
• W3199164501 cites W2147544708 @default.
• W3199164501 cites W2147611159 @default.
• W3199164501 cites W2150558512 @default.
• W3199164501 cites W2150652264 @default.
• W3199164501 cites W2153753874 @default.
• W3199164501 cites W2186365449 @default.
• W3199164501 cites W2282504480 @default.
• W3199164501 cites W2286880442 @default.
• W3199164501 cites W2320534176 @default.
• W3199164501 cites W2415783139 @default.
• W3199164501 cites W2420900831 @default.
• W3199164501 cites W2533261646 @default.
• W3199164501 cites W2533317550 @default.
• W3199164501 cites W2535010553 @default.
• W3199164501 cites W2538854935 @default.
• W3199164501 cites W2555009932 @default.
• W3199164501 cites W2559981814 @default.
• W3199164501 cites W2584088860 @default.
• W3199164501 cites W2587857999 @default.
• W3199164501 cites W2621028470 @default.
• W3199164501 cites W2745962264 @default.
• W3199164501 cites W2810986710 @default.
• W3199164501 cites W2885169386 @default.
• W3199164501 cites W2887075890 @default.
• W3199164501 cites W2900195724 @default.
• W3199164501 cites W2955477855 @default.
• W3199164501 cites W2970401214 @default.
• W3199164501 cites W2989989947 @default.
• W3199164501 doi "https://doi.org/10.1101/2021.09.03.21263089" @default.
• W3199164501 hasPublicationYear "2021" @default.
• W3199164501 type Work @default.
• W3199164501 sameAs 3199164501 @default.
• W3199164501 citedByCount "0" @default.
• W3199164501 crossrefType "posted-content" @default.
• W3199164501 hasAuthorship W3199164501A5000280092 @default.
• W3199164501 hasAuthorship W3199164501A5012480603 @default.
• W3199164501 hasAuthorship W3199164501A5014466276 @default.
• W3199164501 hasAuthorship W3199164501A5019579007 @default.
• W3199164501 hasAuthorship W3199164501A5023494741 @default.
• W3199164501 hasAuthorship W3199164501A5026246111 @default.
• W3199164501 hasAuthorship W3199164501A5049397082 @default.
• W3199164501 hasAuthorship W3199164501A5051260628 @default.
• W3199164501 hasAuthorship W3199164501A5057099256 @default.
• W3199164501 hasAuthorship W3199164501A5065120166 @default.
• W3199164501 hasAuthorship W3199164501A5081891723 @default.
• W3199164501 hasAuthorship W3199164501A5083663416 @default.
• W3199164501 hasAuthorship W3199164501A5086050635 @default.
• W3199164501 hasAuthorship W3199164501A5087874003 @default.
• W3199164501 hasAuthorship W3199164501A5091766125 @default.
• W3199164501 hasBestOaLocation W31991645011 @default.
• W3199164501 hasConcept C126322002 @default.
• W3199164501 hasConcept C159047783 @default.
• W3199164501 hasConcept C197934379 @default.
• W3199164501 hasConcept C2522874641 @default.
• W3199164501 hasConcept C2775999097 @default.
• W3199164501 hasConcept C2776408679 @default.
• W3199164501 hasConcept C2776455275 @default.
• W3199164501 hasConcept C2778375690 @default.
• W3199164501 hasConcept C2778390639 @default.
• W3199164501 hasConcept C2780040827 @default.
• W3199164501 hasConcept C71924100 @default.
• W3199164501 hasConceptScore W3199164501C126322002 @default.
• W3199164501 hasConceptScore W3199164501C159047783 @default.
• W3199164501 hasConceptScore W3199164501C197934379 @default.
• W3199164501 hasConceptScore W3199164501C2522874641 @default.
• W3199164501 hasConceptScore W3199164501C2775999097 @default.
• W3199164501 hasConceptScore W3199164501C2776408679 @default.
• W3199164501 hasConceptScore W3199164501C2776455275 @default.
• W3199164501 hasConceptScore W3199164501C2778375690 @default.
• W3199164501 hasConceptScore W3199164501C2778390639 @default.
• W3199164501 hasConceptScore W3199164501C2780040827 @default.

• next